nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—ABCB1—adrenal gland cancer	0.629	1	CbGaD
Trifluoperazine—CALM2—adrenal medulla—adrenal gland cancer	0.0173	0.114	CbGeAlD
Trifluoperazine—CALM1—adrenal medulla—adrenal gland cancer	0.0172	0.114	CbGeAlD
Trifluoperazine—CALM1—sympathetic nervous system—adrenal gland cancer	0.0114	0.0757	CbGeAlD
Trifluoperazine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00697	0.0461	CbGeAlD
Trifluoperazine—HTR2A—vein—adrenal gland cancer	0.00652	0.0431	CbGeAlD
Trifluoperazine—S100A4—adrenal cortex—adrenal gland cancer	0.0058	0.0383	CbGeAlD
Trifluoperazine—CALY—pituitary gland—adrenal gland cancer	0.00542	0.0359	CbGeAlD
Trifluoperazine—EBPL—adrenal gland—adrenal gland cancer	0.0053	0.035	CbGeAlD
Trifluoperazine—CYP1A2—urine—adrenal gland cancer	0.00488	0.0323	CbGeAlD
Trifluoperazine—TNNC1—adrenal cortex—adrenal gland cancer	0.00488	0.0323	CbGeAlD
Trifluoperazine—S100A4—cardiac atrium—adrenal gland cancer	0.00479	0.0317	CbGeAlD
Trifluoperazine—S100A4—pituitary gland—adrenal gland cancer	0.00468	0.031	CbGeAlD
Trifluoperazine—S100A4—adrenal gland—adrenal gland cancer	0.00418	0.0277	CbGeAlD
Trifluoperazine—TNNC1—cardiac atrium—adrenal gland cancer	0.00403	0.0267	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—adrenal gland cancer	0.00394	0.0261	CbGeAlD
Trifluoperazine—HTR2A—urine—adrenal gland cancer	0.00382	0.0253	CbGeAlD
Trifluoperazine—TNNC1—adrenal gland—adrenal gland cancer	0.00352	0.0233	CbGeAlD
Trifluoperazine—CALM3—adrenal cortex—adrenal gland cancer	0.00212	0.0141	CbGeAlD
Trifluoperazine—SIGMAR1—adrenal cortex—adrenal gland cancer	0.0019	0.0126	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—adrenal gland cancer	0.00179	0.324	CrCbGaD
Trifluoperazine—CALM3—cardiac atrium—adrenal gland cancer	0.00176	0.0116	CbGeAlD
Trifluoperazine—CALM3—pituitary gland—adrenal gland cancer	0.00172	0.0114	CbGeAlD
Trifluoperazine—CALM2—adrenal cortex—adrenal gland cancer	0.00167	0.011	CbGeAlD
Trifluoperazine—CALM1—adrenal cortex—adrenal gland cancer	0.00166	0.011	CbGeAlD
Trifluoperazine—SIGMAR1—cardiac atrium—adrenal gland cancer	0.00157	0.0104	CbGeAlD
Trifluoperazine—SIGMAR1—pituitary gland—adrenal gland cancer	0.00153	0.0101	CbGeAlD
Trifluoperazine—CALM3—adrenal gland—adrenal gland cancer	0.00153	0.0101	CbGeAlD
Trifluoperazine—CALM2—gonad—adrenal gland cancer	0.00138	0.00914	CbGeAlD
Trifluoperazine—CALM2—cardiac atrium—adrenal gland cancer	0.00138	0.00913	CbGeAlD
Trifluoperazine—CALM1—gonad—adrenal gland cancer	0.00138	0.0091	CbGeAlD
Trifluoperazine—CALM1—cardiac atrium—adrenal gland cancer	0.00137	0.00909	CbGeAlD
Trifluoperazine—SIGMAR1—adrenal gland—adrenal gland cancer	0.00137	0.00907	CbGeAlD
Trifluoperazine—CALM2—pituitary gland—adrenal gland cancer	0.00135	0.00892	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—adrenal gland cancer	0.00134	0.00888	CbGeAlD
Trifluoperazine—DRD2—pituitary gland—adrenal gland cancer	0.00124	0.0082	CbGeAlD
Trifluoperazine—HTR1A—adrenal gland—adrenal gland cancer	0.00123	0.0081	CbGeAlD
Trifluoperazine—CALM2—adrenal gland—adrenal gland cancer	0.0012	0.00797	CbGeAlD
Trifluoperazine—CALM1—adrenal gland—adrenal gland cancer	0.0012	0.00793	CbGeAlD
Trifluoperazine—ADRA1A—adrenal gland—adrenal gland cancer	0.00113	0.00747	CbGeAlD
Trifluoperazine—HRH1—adrenal gland—adrenal gland cancer	0.000874	0.00578	CbGeAlD
Trifluoperazine—HTR2A—gonad—adrenal gland cancer	0.000838	0.00554	CbGeAlD
Trifluoperazine—HTR2A—pituitary gland—adrenal gland cancer	0.000817	0.00541	CbGeAlD
Trifluoperazine—Flupentixol—ABCB1—adrenal gland cancer	0.000805	0.146	CrCbGaD
Trifluoperazine—HTR2A—adrenal gland—adrenal gland cancer	0.00073	0.00483	CbGeAlD
Trifluoperazine—ABCB1—adrenal cortex—adrenal gland cancer	0.000663	0.00438	CbGeAlD
Trifluoperazine—ABCB1—gonad—adrenal gland cancer	0.000549	0.00363	CbGeAlD
Trifluoperazine—ABCB1—pituitary gland—adrenal gland cancer	0.000536	0.00354	CbGeAlD
Trifluoperazine—ABCB1—adrenal gland—adrenal gland cancer	0.000479	0.00317	CbGeAlD
Trifluoperazine—Nefazodone—ABCB1—adrenal gland cancer	0.00045	0.0816	CrCbGaD
Trifluoperazine—Triflupromazine—ABCB1—adrenal gland cancer	0.000438	0.0795	CrCbGaD
Trifluoperazine—Trazodone—ABCB1—adrenal gland cancer	0.000416	0.0755	CrCbGaD
Trifluoperazine—Fluphenazine—ABCB1—adrenal gland cancer	0.000337	0.0611	CrCbGaD
Trifluoperazine—Clomipramine—ABCB1—adrenal gland cancer	0.000308	0.0559	CrCbGaD
Trifluoperazine—Promethazine—ABCB1—adrenal gland cancer	0.000273	0.0495	CrCbGaD
Trifluoperazine—Quetiapine—ABCB1—adrenal gland cancer	0.000261	0.0474	CrCbGaD
Trifluoperazine—Clozapine—ABCB1—adrenal gland cancer	0.000225	0.0408	CrCbGaD
Trifluoperazine—Chlorpromazine—ABCB1—adrenal gland cancer	0.000211	0.0384	CrCbGaD
Trifluoperazine—CALM3—Signaling Pathways—SPRY2—adrenal gland cancer	4.28e-05	0.0002	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PRKACA—adrenal gland cancer	4.28e-05	0.000199	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.25e-05	0.000198	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	4.23e-05	0.000197	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	4.18e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TSHR—adrenal gland cancer	4.17e-05	0.000195	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—EGFR—adrenal gland cancer	4.16e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—EGFR—adrenal gland cancer	4.16e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CDC42—adrenal gland cancer	4.16e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CDC42—adrenal gland cancer	4.16e-05	0.000194	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	4.16e-05	0.000194	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SPRY2—adrenal gland cancer	4.14e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SPRY2—adrenal gland cancer	4.14e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PRKACA—adrenal gland cancer	4.14e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PRKACA—adrenal gland cancer	4.14e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—GNAS—adrenal gland cancer	4.11e-05	0.000192	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TSHR—adrenal gland cancer	4.04e-05	0.000188	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TSHR—adrenal gland cancer	4.04e-05	0.000188	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	3.99e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	3.99e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—GNAS—adrenal gland cancer	3.98e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—GNAS—adrenal gland cancer	3.98e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CDC42—adrenal gland cancer	3.93e-05	0.000183	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MEN1—adrenal gland cancer	3.92e-05	0.000183	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	3.86e-05	0.00018	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TERT—adrenal gland cancer	3.84e-05	0.000179	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	3.84e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CDC42—adrenal gland cancer	3.8e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CDC42—adrenal gland cancer	3.8e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MEN1—adrenal gland cancer	3.8e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MEN1—adrenal gland cancer	3.8e-05	0.000177	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.78e-05	0.000176	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	3.73e-05	0.000174	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MED12—adrenal gland cancer	3.72e-05	0.000173	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	3.67e-05	0.000171	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	3.67e-05	0.000171	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	3.66e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CDC42—adrenal gland cancer	3.63e-05	0.000169	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.61e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	3.6e-05	0.000168	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	3.6e-05	0.000168	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	3.59e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PRKACA—adrenal gland cancer	3.58e-05	0.000167	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	3.54e-05	0.000165	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	3.54e-05	0.000165	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	3.53e-05	0.000165	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	3.53e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CDC42—adrenal gland cancer	3.51e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CDC42—adrenal gland cancer	3.51e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PRKACA—adrenal gland cancer	3.47e-05	0.000162	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PRKACA—adrenal gland cancer	3.47e-05	0.000162	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	3.42e-05	0.000159	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	3.4e-05	0.000158	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.39e-05	0.000158	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	3.39e-05	0.000158	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	3.37e-05	0.000157	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—BAD—adrenal gland cancer	3.34e-05	0.000156	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.33e-05	0.000155	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	3.33e-05	0.000155	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.3e-05	0.000154	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.29e-05	0.000153	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	3.27e-05	0.000153	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	3.26e-05	0.000152	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.11e-05	0.000145	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CTNNB1—adrenal gland cancer	3.1e-05	0.000144	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—POMC—adrenal gland cancer	3.08e-05	0.000144	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.06e-05	0.000143	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.05e-05	0.000142	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	3.04e-05	0.000142	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	3.01e-05	0.00014	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3e-05	0.00014	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CTNNB1—adrenal gland cancer	3e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CTNNB1—adrenal gland cancer	3e-05	0.00014	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PRKACA—adrenal gland cancer	3e-05	0.00014	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	2.97e-05	0.000139	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MED12—adrenal gland cancer	2.97e-05	0.000138	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	2.95e-05	0.000138	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	2.95e-05	0.000137	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	2.94e-05	0.000137	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	2.93e-05	0.000136	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	2.92e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TERT—adrenal gland cancer	2.91e-05	0.000136	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—GNAS—adrenal gland cancer	2.9e-05	0.000135	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	2.9e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PRKACA—adrenal gland cancer	2.9e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PRKACA—adrenal gland cancer	2.9e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	2.9e-05	0.000135	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	2.89e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	2.87e-05	0.000134	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	2.86e-05	0.000133	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.85e-05	0.000133	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ABCB1—adrenal gland cancer	2.85e-05	0.000133	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	2.85e-05	0.000133	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	2.84e-05	0.000132	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	2.83e-05	0.000132	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TERT—adrenal gland cancer	2.82e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TERT—adrenal gland cancer	2.82e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—GNAS—adrenal gland cancer	2.81e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—GNAS—adrenal gland cancer	2.81e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.8e-05	0.000131	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	2.79e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—POMC—adrenal gland cancer	2.77e-05	0.000129	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ABCB1—adrenal gland cancer	2.76e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ABCB1—adrenal gland cancer	2.76e-05	0.000128	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—BAD—adrenal gland cancer	2.74e-05	0.000128	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.72e-05	0.000127	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—POMC—adrenal gland cancer	2.68e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—POMC—adrenal gland cancer	2.68e-05	0.000125	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.66e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—BAD—adrenal gland cancer	2.65e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—BAD—adrenal gland cancer	2.65e-05	0.000124	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDC42—adrenal gland cancer	2.54e-05	0.000118	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—BAD—adrenal gland cancer	2.53e-05	0.000118	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.5e-05	0.000116	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.47e-05	0.000115	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.46e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDC42—adrenal gland cancer	2.46e-05	0.000115	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDC42—adrenal gland cancer	2.46e-05	0.000115	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.46e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—EGFR—adrenal gland cancer	2.45e-05	0.000114	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.45e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—BAD—adrenal gland cancer	2.45e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—BAD—adrenal gland cancer	2.45e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF2—adrenal gland cancer	2.45e-05	0.000114	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GNAS—adrenal gland cancer	2.43e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.41e-05	0.000112	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.4e-05	0.000112	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—EGFR—adrenal gland cancer	2.37e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—EGFR—adrenal gland cancer	2.37e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF2—adrenal gland cancer	2.37e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF2—adrenal gland cancer	2.37e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1R—adrenal gland cancer	2.37e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—EGFR—adrenal gland cancer	2.36e-05	0.00011	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GNAS—adrenal gland cancer	2.35e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GNAS—adrenal gland cancer	2.35e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—BRAF—adrenal gland cancer	2.31e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1R—adrenal gland cancer	2.29e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.29e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—adrenal gland cancer	2.29e-05	0.000107	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—EGFR—adrenal gland cancer	2.28e-05	0.000106	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—EGFR—adrenal gland cancer	2.28e-05	0.000106	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.28e-05	0.000106	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.27e-05	0.000106	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.25e-05	0.000105	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.24e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—BRAF—adrenal gland cancer	2.23e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—BRAF—adrenal gland cancer	2.23e-05	0.000104	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—adrenal gland cancer	2.21e-05	0.000103	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—adrenal gland cancer	2.21e-05	0.000103	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.2e-05	0.000103	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	2.2e-05	0.000102	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.18e-05	0.000102	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.17e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.17e-05	0.000101	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.17e-05	0.000101	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.14e-05	9.96e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.13e-05	9.93e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.12e-05	9.87e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	2.1e-05	9.78e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.09e-05	9.75e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TERT—adrenal gland cancer	2.04e-05	9.5e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2e-05	9.33e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	1.98e-05	9.21e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TERT—adrenal gland cancer	1.97e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TERT—adrenal gland cancer	1.97e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	1.97e-05	9.18e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	1.97e-05	9.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—POMC—adrenal gland cancer	1.96e-05	9.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	1.94e-05	9.06e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	1.94e-05	9.04e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	1.93e-05	9.01e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	1.93e-05	8.99e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	1.92e-05	8.93e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	1.91e-05	8.9e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	1.9e-05	8.87e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—POMC—adrenal gland cancer	1.89e-05	8.81e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—POMC—adrenal gland cancer	1.89e-05	8.81e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.89e-05	8.78e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	1.88e-05	8.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—adrenal gland cancer	1.86e-05	8.68e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.85e-05	8.63e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.85e-05	8.6e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CTNNB1—adrenal gland cancer	1.8e-05	8.41e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—adrenal gland cancer	1.8e-05	8.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—adrenal gland cancer	1.8e-05	8.39e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—BAD—adrenal gland cancer	1.77e-05	8.26e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.76e-05	8.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CTNNB1—adrenal gland cancer	1.75e-05	8.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CTNNB1—adrenal gland cancer	1.75e-05	8.14e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	1.74e-05	8.12e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.72e-05	8.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—BAD—adrenal gland cancer	1.72e-05	7.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—BAD—adrenal gland cancer	1.72e-05	7.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CTNNB1—adrenal gland cancer	1.67e-05	7.77e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—POMC—adrenal gland cancer	1.63e-05	7.62e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.63e-05	7.58e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.62e-05	7.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—BRAF—adrenal gland cancer	1.61e-05	7.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CTNNB1—adrenal gland cancer	1.61e-05	7.51e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CTNNB1—adrenal gland cancer	1.61e-05	7.51e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—POMC—adrenal gland cancer	1.58e-05	7.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—POMC—adrenal gland cancer	1.58e-05	7.37e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—EGFR—adrenal gland cancer	1.56e-05	7.29e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—BRAF—adrenal gland cancer	1.56e-05	7.28e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—BRAF—adrenal gland cancer	1.56e-05	7.28e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—adrenal gland cancer	1.56e-05	7.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.51e-05	7.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.51e-05	7.05e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—adrenal gland cancer	1.51e-05	7.03e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—adrenal gland cancer	1.51e-05	7.03e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.48e-05	6.91e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—adrenal gland cancer	1.46e-05	6.81e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—adrenal gland cancer	1.43e-05	6.66e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.43e-05	6.66e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.41e-05	6.55e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.4e-05	6.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—adrenal gland cancer	1.38e-05	6.45e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—adrenal gland cancer	1.38e-05	6.45e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.38e-05	6.43e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.38e-05	6.41e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—adrenal gland cancer	1.32e-05	6.15e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.29e-05	6.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.28e-05	5.98e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—adrenal gland cancer	1.28e-05	5.95e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—adrenal gland cancer	1.28e-05	5.95e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.18e-05	5.51e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.18e-05	5.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.17e-05	5.44e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.13e-05	5.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.13e-05	5.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.13e-05	5.26e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.11e-05	5.19e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.11e-05	5.18e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	1.09e-05	5.1e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.09e-05	5.08e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.08e-05	5.04e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.08e-05	5.02e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	9.5e-06	4.43e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	9.44e-06	4.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	9.35e-06	4.36e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	9.33e-06	4.35e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—adrenal gland cancer	9.24e-06	4.31e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.18e-06	4.28e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	9.15e-06	4.27e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—adrenal gland cancer	8.94e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—adrenal gland cancer	8.94e-06	4.17e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—adrenal gland cancer	7.76e-06	3.62e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—adrenal gland cancer	7.51e-06	3.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—adrenal gland cancer	7.51e-06	3.5e-05	CbGpPWpGaD
